{"context":{"query":">>efo>>gwas","source_dataset":"efo","target_dataset":"gwas"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]EFO:0003144,72,EFO:0003144,108,0]["},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"EFO:0003144","source":"EFO:0003144|heart failure","targets":["GCST000104_1|Heart failure|HSPA12A|10|9.000000e-06","GCST000675_1|Heart failure|LINC02450 - MRPS36P5|12|1.000000e-06","GCST000675_10|Heart failure|GNA15|19|6.000000e-06","GCST000675_11|Heart failure|LINC02388 - LRIG3|12|7.000000e-08","GCST000675_12|Heart failure|HNRNPA1P4 - DPPA3P9|8|3.000000e-06","GCST000675_13|Heart failure|MIR4679-2 - CH25H|10|8.000000e-06","GCST000675_14|Heart failure|NAP1L1P1 - RPUSD4|11|3.000000e-06","GCST000675_15|Heart failure|HLX-AS1|1|7.000000e-06","GCST000675_16|Heart failure|LINC01322|3|6.000000e-06","GCST000675_2|Heart failure|TEX51 - RNU7-182P|2|3.000000e-06","GCST000675_3|Heart failure|ADAMTSL1|9|7.000000e-07","GCST000675_4|Heart failure|TMTC1 - LINC02386|12|3.000000e-06","GCST000675_5|Heart failure|LINC02404 - LINC01619|12|2.000000e-06","GCST000675_6|Heart failure|LINC02568 - USP3|15|1.000000e-08","GCST000675_7|Heart failure|RPL35P4 - HNRNPA1P73|7|7.000000e-06","GCST000675_8|Heart failure|EMICERI|9|5.000000e-06","GCST000675_9|Heart failure|SSR1P2 - CTAGE11P|13|6.000000e-07","GCST004044_1|Age-related diseases and mortality|BSX - SAE1P1|11|5.000000e-10","GCST004044_10|Age-related diseases and mortality|THEMIS3P - AKR1B1P6|18|6.000000e-64","GCST004044_11|Age-related diseases and mortality|CDKN2B-AS1|9|1.000000e-06","GCST004044_12|Age-related diseases and mortality|MX1|21|1.000000e-08","GCST004044_13|Age-related diseases and mortality|FAM238C - ANKRD26|10|2.000000e-08","GCST004044_14|Age-related diseases and mortality|TCF7L2|10|2.000000e-09","GCST004044_2|Age-related diseases and mortality|TEAD4 - RPL13AP24|12|2.000000e-06","GCST004044_3|Age-related diseases and mortality|GRHL1|2|6.000000e-07","GCST004044_4|Age-related diseases and mortality|METAP2P1 - RNU7-2P|2|5.000000e-10","GCST004044_5|Age-related diseases and mortality|ITPK1|14|5.000000e-16","GCST004044_6|Age-related diseases and mortality|SEMA5B|3|8.000000e-22","GCST004044_7|Age-related diseases and mortality|ZFHX3|16|5.000000e-10","GCST004044_8|Age-related diseases and mortality|DNAH2|17|5.000000e-06","GCST004044_9|Age-related diseases and mortality|FERD3L - POLR1F|7|5.000000e-07","GCST004045_1|Age-related diseases, mortality and associated endophenotypes|ZFHX3|16|3.000000e-11","GCST004045_10|Age-related diseases, mortality and associated endophenotypes|SLC30A3|2|8.000000e-10","GCST004045_11|Age-related diseases, mortality and associated endophenotypes|PPM1G - NRBP1|2|1.000000e-31","GCST004045_12|Age-related diseases, mortality and associated endophenotypes|GCKR|2|4.000000e-91","GCST004045_13|Age-related diseases, mortality and associated endophenotypes|METAP2P1 - RNU7-2P|2|8.000000e-07","GCST004045_14|Age-related diseases, mortality and associated endophenotypes|ABCA12|2|4.000000e-06","GCST004045_15|Age-related diseases, mortality and associated endophenotypes|SEMA5B|3|7.000000e-19","GCST004045_16|Age-related diseases, mortality and associated endophenotypes|SLC39A8|4|8.000000e-08","GCST004045_17|Age-related diseases, mortality and associated endophenotypes|LINC01438 - MIR297|4|1.000000e-07","GCST004045_18|Age-related diseases, mortality and associated endophenotypes|MAML3|4|5.000000e-08","GCST004045_19|Age-related diseases, mortality and associated endophenotypes|ANKRD31 - HMGCR|5|9.000000e-12","GCST004045_2|Age-related diseases, mortality and associated endophenotypes|THEMIS3P - AKR1B1P6|18|5.000000e-67","GCST004045_20|Age-related diseases, mortality and associated endophenotypes|CERT1|5|2.000000e-08","GCST004045_21|Age-related diseases, mortality and associated endophenotypes|POLK|5|3.000000e-08","GCST004045_22|Age-related diseases, mortality and associated endophenotypes|POC5|5|3.000000e-06","GCST004045_23|Age-related diseases, mortality and associated endophenotypes|FERD3L - POLR1F|7|5.000000e-07","GCST004045_24|Age-related diseases, mortality and associated endophenotypes|BAZ1B|7|1.000000e-17","GCST004045_25|Age-related diseases, mortality and associated endophenotypes|MLXIPL - VPS37D|7|9.000000e-15","GCST004045_26|Age-related diseases, mortality and associated endophenotypes|FADS1, FADS2|11|7.000000e-25","GCST004045_27|Age-related diseases, mortality and associated endophenotypes|ZPR1|11|2.000000e-108","GCST004045_28|Age-related diseases, mortality and associated endophenotypes|SIK3|11|1.000000e-09","GCST004045_29|Age-related diseases, mortality and associated endophenotypes|BSX - SAE1P1|11|2.000000e-07","GCST004045_3|Age-related diseases, mortality and associated endophenotypes|SUGP1|19|4.000000e-11","GCST004045_30|Age-related diseases, mortality and associated endophenotypes|TEAD4 - RPL13AP24|12|2.000000e-07","GCST004045_31|Age-related diseases, mortality and associated endophenotypes|ATP2B1|12|4.000000e-07","GCST004045_32|Age-related diseases, mortality and associated endophenotypes|ZCCHC8|12|8.000000e-07","GCST004045_33|Age-related diseases, mortality and associated endophenotypes|ITPK1|14|9.000000e-15","GCST004045_34|Age-related diseases, mortality and associated endophenotypes|ALDH1A2, LIPC-AS1, LIPC|15|2.000000e-35","GCST004045_35|Age-related diseases, mortality and associated endophenotypes|FTO|16|1.000000e-14","GCST004045_36|Age-related diseases, mortality and associated endophenotypes|HERPUD1 - CETP|16|1.000000e-149","GCST004045_37|Age-related diseases, mortality and associated endophenotypes|LPL - RPL30P9|8|2.000000e-44","GCST004045_38|Age-related diseases, mortality and associated endophenotypes|TRIB1 - TRIB1AL|8|3.000000e-18","GCST004045_39|Age-related diseases, mortality and associated endophenotypes|CDKN2B-AS1|9|9.000000e-08","GCST004045_4|Age-related diseases, mortality and associated endophenotypes|APOC1|19|1.000000e-22","GCST004045_40|Age-related diseases, mortality and associated endophenotypes|PLCG1|20|7.000000e-07","GCST004045_41|Age-related diseases, mortality and associated endophenotypes|ZHX3 - ADI1P1|20|6.000000e-07","GCST004045_42|Age-related diseases, mortality and associated endophenotypes|MX1|21|4.000000e-06","GCST004045_43|Age-related diseases, mortality and associated endophenotypes|FAM238C - ANKRD26|10|5.000000e-06","GCST004045_44|Age-related diseases, mortality and associated endophenotypes|TCF7L2|10|8.000000e-17","GCST004045_5|Age-related diseases, mortality and associated endophenotypes|CEACAM16-AS1 - BCL3|19|1.000000e-13","GCST004045_6|Age-related diseases, mortality and associated endophenotypes|CELSR2|1|1.000000e-49","GCST004045_7|Age-related diseases, mortality and associated endophenotypes|GRHL1|2|3.000000e-06","GCST004045_8|Age-related diseases, mortality and associated endophenotypes|APOB - TDRD15|2|5.000000e-21","GCST004045_9|Age-related diseases, mortality and associated endophenotypes|TDRD15 - NUTF2P8|2|4.000000e-16","GCST009541_1|Heart failure|CELSR2|1|3.000000e-10","GCST009541_10|Heart failure|BAG3|10|4.000000e-09","GCST009541_11|Heart failure|ATXN2|12|5.000000e-08","GCST009541_12|Heart failure|FTO|16|1.000000e-08","GCST009541_2|Heart failure|PITX2 - LINC01438|4|6.000000e-20","GCST009541_3|Heart failure|KLHL3|5|2.000000e-08","GCST009541_4|Heart failure|CDKN1A|6|7.000000e-09","GCST009541_5|Heart failure|LPA|6|2.000000e-11","GCST009541_6|Heart failure|LPA|6|8.000000e-11","GCST009541_7|Heart failure|CDKN2B-AS1|9|2.000000e-15","GCST009541_8|Heart failure|ABO - Y_RNA|9|4.000000e-09","GCST009541_9|Heart failure|SYNPO2L-AS1, SYNPO2L|10|1.000000e-09","GCST90018586_1|Chronic heart failure|||5.000000e-08","GCST90018586_2|Chronic heart failure|AOPEP|9|6.000000e-09","GCST90018586_3|Chronic heart failure|TBX3-AS1 - UBA52P7|12|3.000000e-08","GCST90018806_1|Chronic heart failure|PITX2 - LINC01438|4|9.000000e-17","GCST90018806_2|Chronic heart failure|CASC15|6|2.000000e-08","GCST90018806_3|Chronic heart failure|RNU1-88P - Y_RNA|6|1.000000e-12","GCST90018806_4|Chronic heart failure|ABO - Y_RNA|9|1.000000e-08","GCST90018806_5|Chronic heart failure|CDKN2B-AS1|9|9.000000e-09","GCST90018806_6|Chronic heart failure|AOPEP|9|6.000000e-09","GCST90018806_7|Chronic heart failure|AVEN|15|4.000000e-08","GCST90018806_8|Chronic heart failure|ZFHX3|16|3.000000e-09","GCST90018806_9|Chronic heart failure|||5.000000e-08","GCST90085925_1|Body fat percentage or heart failure (MTAG)|LPA|6|4.000000e-09"]}]}